Skip to main content

Advertisement

SpringerLink
Log in

Guillain-Barré syndrome and myasthenia gravis in the context of autoimmune polyendocrine syndrome type III

  • Letter to the Editor
  • Published:
Neurological Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cao Y, Gui M, Ji S, Bu B (2019) Guillain-Barré syndrome associated with myasthenia gravis: Three cases report and a literature review. Medicine. 98(47):e18104

    Article  Google Scholar 

  2. Misra UK, Kalita J, Singh VK, Kumar S (2020) A study of comorbidities in myasthenia gravis. Acta Neurol Belg 120(1):59–64

    Article  Google Scholar 

  3. Polizzi A, Ruggieri M, Vecchio I, Genovese S, Rampello L, Raffaele R (2001) Autoimmune thyroiditis and acquired demyelinating polyradiculoneuropathy. Clin Neurol Neurosurg 103(3):151–154

    Article  CAS  Google Scholar 

  4. Pham-Dobor G, Hanák L, Hegyi P, Márta K, Párniczky A, Gergics M, et al (2020) Prevalence of other autoimmune diseases in polyglandular autoimmune syndromes type II and III. J Endocrinol Invest 43(9):1–9

  5. Kahaly GJ (2009) Polyglandular autoimmune syndromes. Eur J Endocrinol 161(1):11–20

    Article  CAS  Google Scholar 

  6. Fallahi P, Ferrari SM, Ruffilli I, Elia G, Biricotti M, Vita R et al (2016) The association of other autoimmune diseases in patients with autoimmune thyroiditis: review of the literature and report of a large series of patients. Autoimmun Rev 15(12):1125–1128

    Article  CAS  Google Scholar 

  7. Eisenbarth GS, Gottlieb PA (2004) Autoimmune polyendocrine syndromes. N Engl J Med 350(20):2068–2079

    Article  CAS  Google Scholar 

  8. Di Stefano V, Barbone F, Ferrante C, Telese R, Vitale M, Onofrj M et al (2020) Inflammatory polyradiculoneuropathies: clinical and immunological aspects, current therapies, and future perspectives. European Journal of Inflammation 18:2058739220942340

    Article  Google Scholar 

  9. Morren J, Li Y (2020) Maintenance immunosuppression in myasthenia gravis, an update. J Neurol Sci. 410:116648

    Article  CAS  Google Scholar 

  10. Carlander B, Touchon J, Georgesco M, Cadilhac J (1991) Myasthenia gravis and recurrent Guillain-Barré syndrome. Neurology. 41(11):1848

    Article  CAS  Google Scholar 

  11. Briscoe NK, Mezei MM (2009) Polyglandular autoimmune syndrome type 3 in a patient with ocular myasthenia gravis. Muscle Nerve 40(6):1064

    Article  Google Scholar 

  12. Wang JY, Pan J, Luo BY, Zhang YY (2011) Temporal coincidence of myasthenia gravis and Guillain Barré syndrome associated with Hashimoto thyroiditis. Neurol Sci 32(3):515

    Article  Google Scholar 

  13. Gobaru M, Ashida K, Yoshinobu S, Nagayama A, Kabashima M, Iwata S et al (2019) Human Leukocyte Antigen (HLA) Subtype-dependent development of myasthenia gravis, type-1 diabetes mellitus, and Hashimoto disease: a case report of autoimmune polyendocrine syndrome type 3. The American journal of case reports 20:1709

    Article  Google Scholar 

  14. Marinó M, Ricciardi R, Pinchera A, Barbesino G, Manetti L, Chiovato L et al (1997) Mild clinical expression of myasthenia gravis associated with autoimmune thyroid diseases. J Clin Endocrinol Metab 82(2):438–443

    PubMed  Google Scholar 

  15. Bowley MP, Chad DA (2019) Clinical neurophysiology of demyelinating polyneuropathy. Handbook of clinical neurology, 161. Elsevier pp 241–268

  16. Yalcin MM, Altinova AE, Cavnar B, Bolayir B, Akturk M, Arslan E et al (2017) Is thyroid autoimmunity itself associated with psychological well-being in euthyroid Hashimoto’s thyroiditis? Endocr J 64(4):425–429

    Article  Google Scholar 

  17. Cook JJ, Hudson I, Harrison LC, Dean B, Colman PG, Werther G et al (1989) Double-blind controlled trial of azathioprine in children with newly diagnosed type I diabetes. Diabetes 38(6):779–783

    Article  CAS  Google Scholar 

  18. Silverstein J, Maclaren N, Riley W, Spillar R, Radjenovic D, Johnson S (1988) Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus. N Engl J Med 319(10):599–604

    Article  CAS  Google Scholar 

  19. Radmanesh M, Saedi K (2006) The efficacy of combined PUVA and low-dose azathioprine for early and enhanced repigmentation in vitiligo patients. J Dermatol Treat 17(3):151–153

    Article  CAS  Google Scholar 

  20. Allam MM, Elzawawy HTH (2018) Induction of remission in autoimmune polyglandular syndrome type three (APS III): an old drug with new perspectives. Clinical case reports 6(11):2178

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neuroscience, Imaging and Clinical Sciences, G. D’Annunzio University, SS Annunziata Hospital, Via dei Vestini, 66100, Chieti, Abruzzo, Italy

    Marianna Gabriella Rispoli, Laura Ferri & Paola Ajdinaj

  2. Center for Neuromuscular Diseases, “SS Annunziata” Hospital, Chieti, Abruzzo, Italy

    Marianna Gabriella Rispoli, Laura Ferri, Paola Ajdinaj & Antonio Di Muzio

  3. Endocrinology Unit, “SS Annunziata” Hospital, Chieti, Abruzzo, Italy

    Valeriana Falzano

  4. Department of Neurology, SS Annunziata Hospital, Chieti, Italy

    Antonio Di Muzio

Authors
  1. Marianna Gabriella Rispoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura Ferri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paola Ajdinaj
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Valeriana Falzano
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Antonio Di Muzio
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

M.G.R., L.F., and P.A. wrote the manuscript and reviewed the literature. V.F. and A.D.M. contributed to the concept, design, and acquisition of key clinical information. All the authors revised the manuscript, and read and approved the final version.

Corresponding author

Correspondence to Marianna Gabriella Rispoli.

Ethics declarations

Patient consent for publication

Obtained.

Data sharing statement

Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.

Ethical approval

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rispoli, M.G., Ferri, L., Ajdinaj, P. et al. Guillain-Barré syndrome and myasthenia gravis in the context of autoimmune polyendocrine syndrome type III. Neurol Sci 42, 4789–4792 (2021). https://doi.org/10.1007/s10072-021-05517-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-021-05517-3

Search

Navigation